NANOG and gastric cancer: To determine if the elevated expression of CMYC, OCT4, SOX2, and NANOG was mediated by the canonical Wnt/β-catenin pathway, we treated GC cells with the β-catenin/TCF inhibitor iCRT14 to block transcriptional activity [20].